Results 291 to 300 of about 17,826,638 (304)

Alemtuzumab for B-cell chronic lymphocytic leukemia.

Issues in emerging health technologies, 2005
Alemtuzumab, a humanized monoclonal antibody, is thought to destroy cancer cells through immune system stimulation or apoptosis induction (programmed cell death). In case series studies using alemtuzumab as salvage therapy, about a third of patients with B-cell chronic lymphocytic leukemia (B-CLL), who were otherwise refractory to chemotherapy ...
openaire   +1 more source

Biology of cancer and the cancer cell: Normal and abnormal regulation of cell reproduction

Ca-A Cancer Journal for Clinicians, 1972
David M Prescott, D M Prescott
exaly  

Small cell anaplastic carcinoma of the lung: Changing concepts and emerging problems

Ca-A Cancer Journal for Clinicians, 1979
J C Ruckdeschel, John C Ruckdeschel
exaly  

Current management of renal cell carcinoma†

Ca-A Cancer Journal for Clinicians, 1996
Jean B Dekernion, Arie Belldegrun, J B Dekernion   +2 more
exaly  

Recent Progress in the Management of Advanced Renal Cell Carcinoma†

Ca-A Cancer Journal for Clinicians, 2007
B I Rini
exaly  

Immunotherapy of renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 1993
Gilda G Hillman, J Edson Pontes, Bruce G Redman   +2 more
exaly  

Current concepts in small cell carcinoma of the lung

Ca-A Cancer Journal for Clinicians, 1984
Philip C Hoffman, Jacob D Bitran, Harvey M Golomb   +2 more
exaly  

Hairy cell leukemia: Diagnosis and management

Ca-A Cancer Journal for Clinicians, 1978
Harvey M Golomb, H M Golomb
exaly  

Improving Outcomes for Patients with Diffuse Large B-cell Lymphoma†

Ca-A Cancer Journal for Clinicians, 2010
Christopher R Flowers, Julie M Vose, Rajni Sinha   +2 more
exaly  

Germ cell and other tumors in individuals with differences in sex development

Ca-A Cancer Journal for Clinicians
Selma Feldman Witchel, Miguel Reyes-Múgica   +1 more
exaly